Cardiology Today -- A mathematic diagnostic prediction model incorporating clinical assessment and N-terminal probrain natriuretic peptide can predict the likelihood of the presence of acute HF. The researchers included 483 patients from the IMPROVE-CHF trial in the analysis.
